Technical Analysis for ABVC - ABVC Biopharma, Inc.

Grade Last Price % Change Price Change
F 0.54 -5.48% -0.03
ABVC closed up 8.04 percent on Wednesday, November 20, 2024, on 16 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.48%
Stochastic Buy Signal Bullish -5.48%
Narrow Range Bar Range Contraction -5.48%
Wide Bands Range Expansion -5.48%
Gapped Up Strength -5.48%
Up 3 Days in a Row Strength -5.48%
Oversold Stochastic Weakness -5.48%
Doji - Bullish? Reversal 2.11%
Wide Bands Range Expansion 2.11%
Oversold Stochastic Weakness 2.11%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown 37 minutes ago
Outside Day 37 minutes ago
Down 5% 37 minutes ago
Down 3% 37 minutes ago
Non-ADX 1,2,3,4 Bearish Retracement Entry 37 minutes ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ABVC Biopharma, Inc. Description

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company was incorporated in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Pancreatic Cancer Depression Major Depressive Disorder Myelodysplastic Syndrome Attention Deficit Hyperactivity Disorder Treatment Of Pancreatic Cancer Triple Negative Breast Cancer

Is ABVC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.18
52 Week Low 0.4053
Average Volume 170,734
200-Day Moving Average 0.88
50-Day Moving Average 0.61
20-Day Moving Average 0.60
10-Day Moving Average 0.53
Average True Range 0.06
RSI (14) 48.72
ADX 14.55
+DI 20.03
-DI 16.71
Chandelier Exit (Long, 3 ATRs) 0.59
Chandelier Exit (Short, 3 ATRs) 0.67
Upper Bollinger Bands 0.76
Lower Bollinger Band 0.43
Percent B (%b) 0.4
BandWidth 54.84
MACD Line -0.02
MACD Signal Line -0.02
MACD Histogram -0.0035
Fundamentals Value
Market Cap 4.49 Million
Num Shares 7.91 Million
EPS -3.57
Price-to-Earnings (P/E) Ratio -0.16
Price-to-Sales 14.34
Price-to-Book 1.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.60
Resistance 3 (R3) 0.60 0.59 0.60
Resistance 2 (R2) 0.59 0.58 0.59 0.60
Resistance 1 (R1) 0.58 0.57 0.58 0.58 0.59
Pivot Point 0.56 0.56 0.56 0.56 0.56
Support 1 (S1) 0.55 0.55 0.56 0.56 0.54
Support 2 (S2) 0.54 0.55 0.54 0.54
Support 3 (S3) 0.53 0.54 0.54
Support 4 (S4) 0.53